Screening Methodologies for the Development of Spray-Dried Amorphous Solid Dispersions
To present a new screening methodology intended to be used in the early development of spray-dried amorphous solid dispersions.
A model that combines thermodynamic, kinetic and manufacturing considerations was implemented to obtain estimates of the miscibility and phase behavior of different itraconazole-based solid dispersions. Additionally, a small-scale solvent casting protocol was developed to enable a fast assessment on the amorphous stability of the different drug-polymer systems. Then, solid dispersions at predefined drug loads were produced in a lab-scale spray dryer for powder characterization and comparison of the results generated by the model and solvent cast samples.
The results obtained with the model enabled the ranking of the polymers from a miscibility standpoint. Such ranking was consistent with the experimental data obtained by solvent casting and spray drying. Moreover, the range of optimal drug load determined by the model was as well consistent with the experimental results.
The screening methodology presented in this work showed that a set of amorphous formulation candidates can be assessed in a computer model, enabling not only the determination of the most suitable polymers, but also of the optimal drug load range to be tested in laboratory experiments. The set of formulation candidates can then be further fine-tuned with solvent casting experiments using a small amount of API, which will then provide the decision for the final candidate formulations to be assessed in spray drying experiments.
Key WordsAmorphous solid dispersion miscibility screening method solvent casting spray drying
Amorphous solid dispersion(s)
Spray dried dispersion(s)
Hydroxypropyl methylcellulose acetate succinate (grade MG)
- PVP/VA 64
Polyvinylpyrrolidone-vinyl acetate copolymer
- Eudragit® EPO
Copolymer of dimethylaminoethyl methacrylate, butyl methacrylate and methyl methacrylate
Glass transition temperature
ACKNOWLEDGMENTS AND DISCLOSURES
Íris Duarte would like to thank the financial support from Hovione Farmaciência SA and from Fundação para a Ciência e Tecnologia through the doctoral grant BDE/51422/2011.
- 1.Lipp R. The Innovator Pipeline: Bioavailability Challenges and Advanced Oral Drug Delivery Opportunities. American Pharmaceutical Review. 2013;16(3).Google Scholar
- 3.Perrie Y, Rades T. Pharmaceutics - Drug Delivery and Targeting: Pharmaceutical Press; 2010.Google Scholar
- 4.Smithey D, Gao P, Taylor L. Amorphous solid dispersions: An enabling formulation technology for oral delivery of poorly water soluble drugs. AAPS Newsmagazine. 2013;16(1):11–4.Google Scholar
- 6.[Online]. Accessed December 2013. Available from: http://www.pharma-iq.com/preclinical-discovery-and-development/articles/ensuring-stability-the-biggestamorphous-challenge/.
- 10.Tian Y, Booth J, Meehan E, Jones DS, Li S, Andrews P. Construction of Drug−Polymer Thermodynamic Phase Diagrams Using Flory−Huggins Interaction Theory: Identifying the Relevance of Temperature and Drug Weight Fraction to Phase Separation within Solid Dispersions. Mol Pharm. 2013;10:236–48.PubMedCrossRefGoogle Scholar
- 15.Kyeremateng SO, Pudlas M, Woehrle GH. A Fast and Reliable Empirical Approach for Estimating Solubility of Crystalline Drugs in Polymers for Hot-Melt Extrusion Formulations. Journal of Pharmaceutical Sciences. 2014.Google Scholar
- 16.Mahieu A, Willart JF, Dudognon E, Danède F, Descamps. A new protocol to determine the solubility of drugs into polymer matrixes. Mol Pharm. 2013;10(2).Google Scholar
- 17.Tao J, Sun Y, Zhang GGZ, Yu L. Solubility of Small-Molecule Crystals in Polymers: D-Mannitol in PVP, Indomethacin in PVP/VA, and Nifedipine in PVP/VA. Pharm Res. 2009;26(4).Google Scholar
- 21.Albers J, Matthée K, Knop K, Kleinebudde P. Evaluation of predictive models for stable solid solution formation. 2011;100(2):667–80.Google Scholar
- 24.Saylor DM. Predicting Microstructure Evolution in Controlled Drug Release Coatings. In FDA/NHLBI/NSF Workshop on Computer Methods for Cardiovascular Devices ; 2010; USA.Google Scholar
- 26.Krevlen DW. Nijenhuis Kt. Properties of Polymers Amsterdam: Elsevier; 2009.Google Scholar
- 29.Wilke CR, Chang P. Correlation of diffusion coeficients in dilute solutions. AIChE Journal. 1955;: p. 264-270.Google Scholar
- 30.Masters K. Spray Drying in Practice Denmark: SprayDry Consult. 2002.Google Scholar
- 32.Poling BE, Prausnitz JM. O'Connell JP. The Properties of Gases and Liquids: McGraw-Hill; 2001.Google Scholar
- 38.Barton AFM. Handbook of Solubility Parameters and Other Cohesion Parameters Florida: Boca Raton, CRC Press; 1983Google Scholar
- 45.Janssens S, Nagels S, de Novoa HA, Van Schepdael A, Van den Mooter G. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm. 2008;69:158–66.PubMedCrossRefGoogle Scholar
- 47.van Drooge DJ, Hinrichs WLJ, Visser MR, Frijlink HW. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int J Pharm. 2006;310:220–9.PubMedCrossRefGoogle Scholar
- 48.Pharmaceutical Development. ICHQ8(R2). Geneva: International Conference on Harmonisation; 2009.Google Scholar